Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francois Mercier

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Statistics in Medicine|June 6, 2022
Extending the Continual Reassessment Method to accommodate step-up dosing in Phase I trialsThomas M Braun, Francois Mercier
Statistics in Medicine|May 25, 2026
Mediation Analysis With Bayesian Nonlinear Joint Models: Evaluation of the Treatment Causal Pathways Between Tumor Growth Kinetics and Overall SurvivalGeorgios Kazantzidis, Francois Mercier, Virginie Rondeau
Pharmaceutical Statistics|June 18, 2015
Characterization of dose-response for count data using a generalized MCP-Mod approach in an adaptive dose-ranging trialFrancois Mercier, Bjoern Bornkamp, David Ohlssen, et al.
Statistics in Medicine|June 1, 2013
Using historical control information for the design and analysis of clinical trials with overdispersed count dataSandro Gsteiger, Beat Neuenschwander, Francois Mercier, et al.
Biophysical Journal|September 26, 2003
Solid phase DNA amplification: a simple Monte Carlo Lattice modelJean-Francois Mercier, Gary W Slater, Pascal Mayer
Radiation Protection Dosimetry|October 18, 2017
A REVIEW OF NATURAL RADIONUCLIDES IN CANADIAN DRINKING WATER (1975-16)Jing Chen, Michael W Cooke, Jean-Francois Mercier
Pharmaceutical Statistics|April 4, 2019
From waterfall plots to spaghetti plots in early oncology clinical developmentFrancois Mercier, Nicola Consalvo, Nicolas Frey, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2007
Immunophenotypic patterns of CD8+ T cell subsets expressing CD8alphaalpha and IL-7Ralpha in viremic, aviremic and slow progressor HIV-1-infected subjectsMohamed-Rachid Boulassel, Francois Mercier, Norbert Gilmore, et al.
Contemporary Clinical Trials Communications|February 24, 2022
Exposure driven dose escalation design with overdose control: Concept and first real life experience in an oncology phase I trialSandrine Micallef, Alexandre Sostelly, Jiawen Zhu, et al.
Biometrics|February 16, 2013
Estimating time to disease progression comparing transition models and survival methods--an analysis of multiple sclerosis dataMicha Mandel, Francois Mercier, Benjamin Eckert, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Statistics in Medicine|June 6, 2022
Extending the Continual Reassessment Method to accommodate step-up dosing in Phase I trialsThomas M Braun, Francois Mercier
Statistics in Medicine|May 25, 2026
Mediation Analysis With Bayesian Nonlinear Joint Models: Evaluation of the Treatment Causal Pathways Between Tumor Growth Kinetics and Overall SurvivalGeorgios Kazantzidis, Francois Mercier, Virginie Rondeau
Pharmaceutical Statistics|June 18, 2015
Characterization of dose-response for count data using a generalized MCP-Mod approach in an adaptive dose-ranging trialFrancois Mercier, Bjoern Bornkamp, David Ohlssen, et al.
Statistics in Medicine|June 1, 2013
Using historical control information for the design and analysis of clinical trials with overdispersed count dataSandro Gsteiger, Beat Neuenschwander, Francois Mercier, et al.
Biophysical Journal|September 26, 2003
Solid phase DNA amplification: a simple Monte Carlo Lattice modelJean-Francois Mercier, Gary W Slater, Pascal Mayer
Radiation Protection Dosimetry|October 18, 2017
A REVIEW OF NATURAL RADIONUCLIDES IN CANADIAN DRINKING WATER (1975-16)Jing Chen, Michael W Cooke, Jean-Francois Mercier
Pharmaceutical Statistics|April 4, 2019
From waterfall plots to spaghetti plots in early oncology clinical developmentFrancois Mercier, Nicola Consalvo, Nicolas Frey, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2007
Immunophenotypic patterns of CD8+ T cell subsets expressing CD8alphaalpha and IL-7Ralpha in viremic, aviremic and slow progressor HIV-1-infected subjectsMohamed-Rachid Boulassel, Francois Mercier, Norbert Gilmore, et al.
Contemporary Clinical Trials Communications|February 24, 2022
Exposure driven dose escalation design with overdose control: Concept and first real life experience in an oncology phase I trialSandrine Micallef, Alexandre Sostelly, Jiawen Zhu, et al.
Biometrics|February 16, 2013
Estimating time to disease progression comparing transition models and survival methods--an analysis of multiple sclerosis dataMicha Mandel, Francois Mercier, Benjamin Eckert, et al.
Pageof 5